This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MetLife (MET) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 13.85% and -0.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
Top Research Reports for Visa, Boeing & Coca-Cola
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Boeing (BA) and Coca-Cola (KO).
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Will MetLife (MET) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Aflac's (AFL) Japan Business to Drive Long-Term Growth
by Zacks Equity Research
Changes in Japan's economy and aging population is likely to drive growth at Aflac (AFL).
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Why Is MetLife (MET) Up 1.8% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
CNO Financial's (CNO) Q4 Earnings Lag Estimates, Fall Y/Y
by Zacks Equity Research
CNO Financial's (CNO) fourth-quarter earnings fall shy of estimates due to lower revenues.
Q4 Earnings Drive Insurance ETFs Higher
by Sweta Killa
The Q4 earnings of insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past month.
Why MetLife (MET) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
MetLife's (MET) Q4 earnings gain from a decline in total expenses and revenues remain flat year over year.
Insurers' Q4 Earnings Roster for Feb 6: MET, PRU, CINF, LNC
by Zacks Equity Research
Insurers are likely to benefit from interest rate hikes, improved pricing, continued share repurchases, though cat loss will weigh on underwriting profitability.
Factors Likely to Shape MetLife (MET) This Earnings Season
by Zacks Equity Research
MetLife (MET) fourth-quarter 2018 earnings should gain from increase in revenues and accretion from share buyback program, partly offset by catastrophe losses.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MGIC Investment (MTG) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
MGIC Investment (MTG) Q4 results reflect lower credit losses, improved net premiums earned, and impact of lower tax and share buybacks.
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why You Should Add Assurant (AIZ) to Your Portfolio
by Zacks Equity Research
Assurant (AIZ) rides on operational excellence and promises better rewards for investors.
MetLife (MET) Gains As Market Dips: What You Should Know
by Zacks Equity Research
MetLife (MET) closed at $43.72 in the latest trading session, marking a +0.81% move from the prior day.
CNO Financial's Subsidiaries Get Ratings From A.M. Best
by Zacks Equity Research
CNO Financial's (CNO) arms receive rating actions from A.M. Best. Outlook is stable.